Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

From biomarkers to a clue of biology: a computation-aided perspective of immune gene expression profiles in human type 1 diabetes.

Han D, Cai X, Wen J, Kenyon NS, Chen Z.

Front Immunol. 2012 Oct 25;3:320. doi: 10.3389/fimmu.2012.00320. eCollection 2012.

2.

Innate and adaptive immune gene expression profiles as biomarkers in human type 1 diabetes.

Han D, Cai X, Wen J, Matheson D, Skyler JS, Kenyon NS, Chen Z.

Clin Exp Immunol. 2012 Nov;170(2):131-8. doi: 10.1111/j.1365-2249.2012.04650.x.

3.

CTLA4 gene variants in autoimmunity and cancer: a comparative review.

Ghaderi A.

Iran J Immunol. 2011 Sep;8(3):127-49. doi: IJIv8i3A1. Review.

4.

Pancreatic islet autoimmunity.

Boitard C.

Presse Med. 2012 Dec;41(12 P 2):e636-50. doi: 10.1016/j.lpm.2012.10.003. Epub 2012 Nov 22. Review.

PMID:
23182678
5.

CBLB variants in type 1 diabetes and their genetic interaction with CTLA4.

Bergholdt R, Taxvig C, Eising S, Nerup J, Pociot F.

J Leukoc Biol. 2005 Apr;77(4):579-85. Epub 2005 Jan 3.

PMID:
15629882
6.

Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery.

Planas R, Pujol-Borrell R, Vives-Pi M.

Immunol Lett. 2010 Oct 30;133(2):55-61. doi: 10.1016/j.imlet.2010.08.001. Epub 2010 Aug 11. Review.

PMID:
20708640
7.

Early suppression of immune response pathways characterizes children with prediabetes in genome-wide gene expression profiling.

Elo LL, Mykkänen J, Nikula T, Järvenpää H, Simell S, Aittokallio T, Hyöty H, Ilonen J, Veijola R, Simell T, Knip M, Simell O, Lahesmaa R.

J Autoimmun. 2010 Aug;35(1):70-6. doi: 10.1016/j.jaut.2010.03.001. Epub 2010 Mar 30.

PMID:
20356713
8.

Targeted immune interventions for type 1 diabetes: not as easy as it looks!

Rigby MR, Ehlers MR.

Curr Opin Endocrinol Diabetes Obes. 2014 Aug;21(4):271-8. doi: 10.1097/MED.0000000000000075. Review.

9.

How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.

Vives-Pi M, Rodríguez-Fernández S, Pujol-Autonell I.

Apoptosis. 2015 Mar;20(3):263-72. doi: 10.1007/s10495-015-1090-8. Review.

10.

Gene expression profiles for the human pancreas and purified islets in type 1 diabetes: new findings at clinical onset and in long-standing diabetes.

Planas R, Carrillo J, Sanchez A, de Villa MC, Nuñez F, Verdaguer J, James RF, Pujol-Borrell R, Vives-Pi M.

Clin Exp Immunol. 2010 Jan;159(1):23-44. doi: 10.1111/j.1365-2249.2009.04053.x. Epub 2009 Nov 11.

11.

Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients 1miR-146.

Yang M, Ye L, Wang B, Gao J, Liu R, Hong J, Wang W, Gu W, Ning G.

J Diabetes. 2015 Mar;7(2):158-65. doi: 10.1111/1753-0407.12163. Epub 2014 Jul 15.

PMID:
24796653
12.

Opposing effects of CTLA4 insufficiency on regulatory versus conventional T cells in autoimmunity converge on effector memory in target tissue.

Devarajan P, Miska J, Lui JB, Swieboda D, Chen Z.

J Immunol. 2014 Nov 1;193(9):4368-80. doi: 10.4049/jimmunol.1400876. Epub 2014 Sep 22.

13.

Differences in B7 and CD28 family gene expression in the peripheral blood between newly diagnosed young-onset and adult-onset type 1 diabetes patients.

Pruul K, Kisand K, Alnek K, Metsküla K, Reimand K, Heilman K, Peet A, Varik K, Peetsalu M, Einberg Ü, Tillmann V, Uibo R.

Mol Cell Endocrinol. 2015 Sep 5;412:265-71. doi: 10.1016/j.mce.2015.05.012. Epub 2015 May 14.

PMID:
25980680
14.

Early over expression of messenger RNA for multiple genes, including insulin, in the Pancreatic Lymph Nodes of NOD mice is associated with Islet Autoimmunity.

Regnault B, Osorio Y Fortea J, Miao D, Eisenbarth G, Melanitou E.

BMC Med Genomics. 2009 Oct 2;2:63. doi: 10.1186/1755-8794-2-63.

15.

Functional evaluation of the type 1 diabetes (T1D) susceptibility candidate genes.

Park Y.

Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S110-5. Epub 2007 Apr 19. Review.

PMID:
17448564
16.

Association of TNF-α, CTLA4, and PTPN22 polymorphisms with type 1 diabetes and other autoimmune diseases in Brazil.

Tavares NA, Santos MM, Moura R, Araújo J, Guimarães RL, Crovella S, Brandão LA.

Genet Mol Res. 2015 Dec 28;14(4):18936-44. doi: 10.4238/2015.December.28.42.

17.

Analyses of regulatory CD4+ CD25+ FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children.

Hamari S, Kirveskoski T, Glumoff V, Kulmala P, Simell O, Knip M, Veijola R.

Scand J Immunol. 2016 Apr;83(4):279-87. doi: 10.1111/sji.12418.

18.

Healthy first-degree relatives of patients with type 1 diabetes exhibit significant differences in basal gene expression pattern of immunocompetent cells compared to controls: expression pattern as predeterminant of autoimmune diabetes.

Stechova K, Kolar M, Blatny R, Halbhuber Z, Vcelakova J, Hubackova M, Petruzelkova L, Sumnik Z, Obermannova B, Pithova P, Stavikova V, Krivjanska M, Neuwirth A, Kolouskova S, Filipp D.

Scand J Immunol. 2012 Feb;75(2):210-9. doi: 10.1111/j.1365-3083.2011.02637.x.

19.

Genetics of the autoimmune polyglandular syndrome type 3 variant.

Dittmar M, Kahaly GJ.

Thyroid. 2010 Jul;20(7):737-43. doi: 10.1089/thy.2010.1639. Review.

PMID:
20578896
20.

Foxp3(+) regulatory T cells in mouse models of type 1 diabetes.

Petzold C, Riewaldt J, Watts D, Sparwasser T, Schallenberg S, Kretschmer K.

J Diabetes Res. 2013;2013:940710. doi: 10.1155/2013/940710. Epub 2013 Mar 14.

Supplemental Content

Support Center